R/R=relapsed/refractory; CLL=chronic lymphocytic leukemia; SLL=small lymphocytic lymphoma; VEN+R=VENCLEXTA + rituximab.

*See NCCN Guidelines for the definitions of Categories of Preference and Categories of Evidence and Consensus.

NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.